Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Nicol, MBChB, PhD
University of Cape Town, Faculty of Health Sciences, Dept. of Medical Microbiology, Cape Town, South Africa
Principal Investigator - Mischka Moodley, MBChB, DTM&H, FCPath(Micro)SA
University of Cape Town, Faculty of Health Sciences, Dept. of Medical Microbiology, Cape Town, South Africa
Principal Investigator - Susan Dorman, MD
Johns Hopkins University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- G.F. Jooste Hospital
Cape Town, Western Cape, South Africa
- Town Two Clinic
Cape Town, Western Cape, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2011
- Primary completion
- 28 Feb 2013
- Completion
- 28 Feb 2013
- Last update posted
- 26 Sept 2012
- Registered enrollment
- 512
- Registry id
- NCT01693224
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.